Fundz

Insight Molecular Diagnostics Inc. Raises $15 Million in Public Offering

PUBLIC · IMDXNov 18, 2026

Amount Raised

$15 Million

Round Type

Post-IPO Equity

IrvineBiotechnologyHealth CareGeneticsHealth Diagnostics

Investors

Lake Street Capital Markets, LLC

Description

On November 17, 2026, Insight Molecular Diagnostics Inc. entered into an underwriting agreement for a public offering of shares and pre-funded warrants. The offering is expected to close on or about November 18, 2026, generating approximately $15.0 million in gross proceeds. The net proceeds will be utilized for working capital and general corporate purposes

Quick answer

Insight Molecular Diagnostics Inc. raised $15 Million in a Post-IPO Equity round, dated November 18, 2026. Investors: Lake Street Capital Markets, LLC. Insight Molecular Diagnostics Inc. is based in Irvine, California, United States.

How much did Insight Molecular Diagnostics Inc. raise?
Insight Molecular Diagnostics Inc. raised $15 Million in a Post-IPO Equity round on November 18, 2026.
Who invested in Insight Molecular Diagnostics Inc?
Lake Street Capital Markets, LLC is named as investors in this round.
What does Insight Molecular Diagnostics Inc. do?
Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Where is Insight Molecular Diagnostics Inc. based and how big is it?
Insight Molecular Diagnostics Inc. is based in Irvine, California, United States. Fundz records about 56 employees.
Who are the decision-makers at Insight Molecular Diagnostics Inc?
Fundz holds 1 contact at Insight Molecular Diagnostics Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Health Diagnostics around the same time

Companies in the same sectors as Insight Molecular Diagnostics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
  • Arboretum LifeSciences raised $30M (Series A) on October 7, 2026.
  • Raywatt raised $9.9M (Series B) on November 16, 2026.
  • Alterra Labs raised $13M (Seed) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.

Who to call at Insight Molecular Diagnostics Inc., and when

A new round usually means Insight Molecular Diagnostics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Insight Molecular Diagnostics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Insight Molecular Diagnostics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Insight Molecular Diagnostics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Insight Molecular Diagnostics Inc.

Location

15 CUSHING

Irvine, California, United States

About

Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Insight Molecular Diagnostics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts10 people are listed at Insight Molecular Diagnos…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Insight Molecular Diagnostics Inc.'s next move

See what Strategic adds

Insight Molecular Diagnostics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.